PROVIDER PROFILE · NPI 1992024434

Kaihong MiMD, PHD

Hematology-OncologyHarrisburg, PAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

584

Unique beneficiaries

—

Total services

843

Distinct HCPCS

Medicare payment

$67K

Peer benchmark

Total Medicare services vs. 417 Hematology-Oncology providers in PA — above median (cohort median 753).

PRESCRIBING · PART D · 2024

Total Rx claims

1,354

Beneficiaries

—

Total drug cost

$2.6M

Distinct drugs

Brand share

30.4%

Top prescribed drugs

Apixaban125 claims

Acyclovir96 claims

Dexamethasone87 claims

Ondansetron Hcl85 claims

Prochlorperazine Maleate83 claims

QUALITY · MIPS · 2024

Final MIPS score

87.9

Quality

78.3

Cost

75.1

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.54%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history